Stock Scorecard
Stock Summary for DBV Technologies (DBVT) - $13.29 as of 10/6/2025 9:41:19 PM EST
Total Score
9 out of 30
Safety Score
24 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DBVT
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DBVT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DBVT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DBVT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DBVT (24 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DBVT
Financial Details for DBVT
Company Overview |
|
|---|---|
| Ticker | DBVT |
| Company Name | DBV Technologies |
| Country | USA |
| Description | DBV Technologies SA (DBVT) is a clinical-stage biopharmaceutical company based in Montrouge, France, focusing on the development of innovative epicutaneous immunotherapy products aimed at treating food allergies. Leveraging its proprietary Viaskin™ technology platform, DBV is committed to enhancing patient outcomes by offering non-invasive treatment options that aim to desensitize individuals to allergens. With a robust pipeline that includes lead candidates targeting peanut allergies and ongoing clinical trials, DBV Technologies is positioned to play a transformative role in the allergy treatment landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 13.29 |
| Price 4 Years Ago | 16.00 |
| Last Day Price Updated | 10/6/2025 9:41:19 PM EST |
| Last Day Volume | 192,766 |
| Average Daily Volume | 60,602 |
| 52-Week High | 14.44 |
| 52-Week Low | 2.20 |
| Last Price to 52 Week Low | 504.09% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 22.22 |
| Sector PE | 41.70 |
| 5-Year Average PE | -14.12 |
| Free Cash Flow Ratio | 3.53 |
| Industry Free Cash Flow Ratio | 14.45 |
| Sector Free Cash Flow Ratio | 30.25 |
| Current Ratio Most Recent Quarter | 2.45 |
| Total Cash Per Share | 3.77 |
| Book Value Per Share Most Recent Quarter | 0.63 |
| Price to Book Ratio | 3.89 |
| Industry Price to Book Ratio | 29.58 |
| Sector Price to Book Ratio | 32.02 |
| Price to Sales Ratio Twelve Trailing Months | 92.89 |
| Industry Price to Sales Ratio Twelve Trailing Months | 44.16 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.22 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 27,362,100 |
| Market Capitalization | 363,642,309 |
| Institutional Ownership | 5.30% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -56.64% |
| Reported EPS 12 Trailing Months | -5.60 |
| Reported EPS Past Year | -0.54 |
| Reported EPS Prior Year | -2.60 |
| Net Income Twelve Trailing Months | -113,652,000 |
| Net Income Past Year | -113,918,000 |
| Net Income Prior Year | -72,726,000 |
| Quarterly Revenue Growth YOY | 26.20% |
| 5-Year Revenue Growth | -29.46% |
| Operating Margin Twelve Trailing Months | -2,806.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 103,207,000 |
| Total Cash Past Year | 32,456,000 |
| Total Cash Prior Year | 141,367,000 |
| Net Cash Position Most Recent Quarter | 103,030,000 |
| Net Cash Position Past Year | 31,913,000 |
| Long Term Debt Past Year | 543,000 |
| Long Term Debt Prior Year | 510,000 |
| Total Debt Most Recent Quarter | 177,000 |
| Equity to Debt Ratio Past Year | 0.98 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 27,388,000 |
| Total Stockholder Equity Prior Year | 140,186,000 |
| Total Stockholder Equity Most Recent Quarter | 86,224,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -89,273,986 |
| Free Cash Flow Per Share Twelve Trailing Months | -3.26 |
| Free Cash Flow Past Year | -106,815,000 |
| Free Cash Flow Prior Year | -80,330,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.66 |
| MACD Signal | 0.19 |
| 20-Day Bollinger Lower Band | 7.42 |
| 20-Day Bollinger Middle Band | 9.94 |
| 20-Day Bollinger Upper Band | 12.46 |
| Beta | 0.43 |
| RSI | 80.56 |
| 50-Day SMA | 9.68 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 11.77 |
System |
|
| Modified | 10/6/2025 9:42:06 PM EST |